How payment cuts shape access to preventive heart screenings

Cardiovascular disease remains Australia's leading cause of death, claiming more than 42,000 lives each year. The system meant to catch heart problems early is quietly being reshaped by decisions about how much Medicare will reimburse clinicians for preventive work. When rebate schedules shrink or stagnate, the consequences reach well beyond clinic balance sheets.

Preventive heart screenings — including ECG checks, lipid panels, blood pressure assessments, and more advanced imaging — rely on a fragile economic chain. General practitioners order them, cardiologists interpret them, and pathology providers process the samples. A reduction in the Medicare Benefits Schedule fee for any link in that chain quickly translates into longer waits, higher gap fees, or fewer services offered at all.

For patients sitting in a suburban waiting room in Parramatta or a community clinic in Townsville, the result feels the same: a recommendation that should take a week now takes a season, and a question worth asking gets pushed to another visit.

The current MBS landscape for cardiac preventive services

The Medicare Benefits Schedule lists the rebate the Australian Government pays for each clinical service. For preventive cardiology, the most relevant items cover GP health assessments, ECG recording and reporting, 24-hour Holter monitoring, lipid studies, and cardiology specialist consultations. Many of these items have not kept pace with inflation or the rising cost of running a practice.

When indexation of MBS rebates was frozen for several years, the real value of each rebate eroded. A service paid $40 a decade ago may still attract roughly that figure today, even though rent, wages, consumables, and indemnity insurance have all climbed. Practices respond in predictable ways: some reduce the time allocated to preventive discussions, others stop bulk billing preventive items, and a few stop offering certain screenings from their rooms. A GP who once included a baseline ECG in a Heart Health Check may now refer the patient elsewhere, and that elsewhere has its own waitlist and fee structure.

Why preventive cardiology matters in Australian communities

Heart disease does not distribute itself evenly across the country. Rates of hospitalisation for acute coronary events are markedly higher in regional and remote areas, among Aboriginal and Torres Strait Islander peoples, and in lower socioeconomic suburbs of capital cities. Preventive screenings work best when they reach people before symptoms force them into an emergency department.

In places like the Pilbara or western New South Wales, a single cardiac event can involve an RFDS retrieval flight and a hospital transfer. Anything that delays detection in those settings carries a cost measured in hours, kilometres, and outcomes. In metropolitan Melbourne or Brisbane, the calculus is different but the principle holds: catching an arrhythmia or a rising coronary risk early avoids admissions that would otherwise cost the public purse far more than the screening itself.

How rebate reductions flow through to patient out-of-pocket costs

When a rebate is cut or held flat, clinicians have three main choices. They can absorb the loss, pass it on as a gap fee, or scale back the service. Each path reshapes access in a different way.

Absorbing the cost works for a time, particularly in practices with high patient volumes. Over years it becomes unsustainable and the service quietly disappears. Practices that pivot to private billing often introduce a gap of $30 to $80 for items that were once bulk billed. Patients without private health insurance, or those whose policies exclude outpatient diagnostics, can find a recommended screening suddenly out of reach. Scaling back is the most insidious option, with a practice deciding that offering a 24-hour Holter monitor no longer pays for the device and the technician time. The service vanishes from the local menu, and patients are told to seek it elsewhere — often a long drive away.

The rural and regional divide in screening availability

Access to preventive cardiology has always been patchy outside the capital cities. Cardiologists cluster around major teaching hospitals, and advanced imaging equipment tends to live in larger centres. Rebate reductions widen that gap rather than narrow it.

In towns like Ballarat, Bunbury, or Cairns, a single visiting cardiologist might service a region covering thousands of square kilometres. When the rebate for that visit does not justify the travel, the visit stops happening. Telehealth fills some of the space, but a remote consult cannot replace an exercise stress test or a transthoracic echo.

Communities already carrying the highest cardiovascular risk feel the impact first. Indigenous health services, rural women's health programs, and outreach clinics in lower socioeconomic suburbs depend on cross-subsidy from better-reimbursed items to fund preventive work. Cutting those items hollows out the preventive layer of care for the people who need it most.

Comparing screening pathways under different funding models

Different funding models produce different patient journeys. The table below compares four common pathways for a patient referred for a basic cardiac workup after an abnormal Heart Health Check.

Pathway	Funding source	Typical out-of-pocket cost	Typical wait	Reach in rural areas
Public outpatient clinic	Public hospital budget	$0	4–12 weeks	Limited; tied to outreach roster
Bulk billed private practice	MBS rebate only	$0	1–3 weeks	Patchy; concentrated in metro areas
Mixed-billing private practice	MBS rebate + patient gap	$30–$90	Under 1 week	Very limited; mostly metro
Community outreach program	Grant funding + MBS	$0–$20	Variable; scheduled visits	Strong in some regions, fragile elsewhere

The cheaper the pathway for the patient, the longer the wait and the narrower the geographic reach. Rebate cuts tend to push practices away from the bulk billed column and into the mixed-billing column, precisely where access thins out.

Stories from the waiting room

A few patterns show up repeatedly when patients and clinicians describe what rebate changes feel like on the ground.

• A retired teacher in the Mornington Peninsula waited eleven weeks for a stress test after her GP flagged chest tightness on exertion, only to learn she could have paid $120 and been seen within the week at a private clinic across town.
• An Aboriginal health worker in the Kimberley reported that a visiting cardiology service had halved its annual visits because the rebate no longer covered the cost of sending a sonographer up from Perth.
• A bulk billing GP in western Sydney stopped offering in-practice ECGs after the consumable cost rose above the rebate, and now refers every patient to a separate provider.
• A cardiologist described how tradies, hospitality workers, and shift workers were the first to drop a recommended screening when an out-of-pocket fee appeared, citing the cost of a missed arvo at work.

What clinicians and patients are asking policymakers to do

Advocates across the sector have converged on a small set of practical asks that go well beyond simple rebate restoration.

• Restore annual indexation to MBS preventive items and apply it retrospectively to items that have been frozen
• Introduce a specific Medicare item number for nurse-led cardiovascular risk assessment in general practice
• Fund a national rural cardiology outreach scheme tied to MBS rebates that reflect the true cost of travel and setup
• Protect bulk billing incentives for preventive items through targeted Practice Incentive Program payments
• Mandate annual reporting on geographic access to basic cardiac diagnostics so that gaps are visible before they widen

These requests sit within a broader push to treat preventive cardiology as core primary care rather than an optional add-on.

Reaching out to your local federal member, sharing a personal story about a delayed screening, or adding your name to a sector petition can shift the conversation in Canberra. Preventive heart care only works when the system funds it properly — and that funding depends on the people who use it speaking up.